Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK Medtech Ponders Future As New Government Gets Up To Speed

Executive Summary

Post-Brexit concerns abound for UK medtech companies who are hoping that a renewed government focus on the life sciences industry will provide the support and benefits it needs amid the uncertainties brought on by the UK vote to leave the European Union.

Advertisement

Related Content

Brexit Reflections For UK IVDs: Harmonized Regulation, Staff Issues Key
UK Medtech Presses For Federation Structure In Post-Brexit Environment
George Freeman Departure Leaves UK Life Sciences Holding Its Breath

Topics

Advertisement
UsernamePublicRestriction

Register

MT103686

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel